These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 14992900)

  • 1. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery.
    Merry AF; Raudkivi PJ; Middleton NG; McDougall JM; Nand P; Mills BP; Webber BJ; Frampton CM; White HD
    Ann Thorac Surg; 2004 Mar; 77(3):925-31; discussion 931. PubMed ID: 14992900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery.
    Merry AF
    Semin Thromb Hemost; 2004 Jun; 30(3):337-46. PubMed ID: 15282656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study.
    Smedira NG; Dyke CM; Koster A; Jurmann M; Bhatia DS; Hu T; McCarthy HL; Lincoff AM; Spiess BD; Aronson S
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):686-92. PubMed ID: 16515924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] trial).
    Parodi G; Migliorini A; Valenti R; Bellandi B; Signorini U; Moschi G; Buonamici P; Cerisano G; Antoniucci D
    Am J Cardiol; 2010 Apr; 105(8):1053-9. PubMed ID: 20381652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
    Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective.
    Palmer GJ; Sankaran IS; Sparkman GM; Koster A; Dyke CM; Ebra G
    Heart Surg Forum; 2008; 11(1):E24-9. PubMed ID: 18270134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia.
    Dyke CM; Koster A; Veale JJ; Maier GW; McNiff T; Levy JH
    Ann Thorac Surg; 2005 Jul; 80(1):299-303. PubMed ID: 15975385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
    Feldman DN; Wong SC; Gade CL; Gidseg DS; Bergman G; Minutello RM
    Am Heart J; 2007 Oct; 154(4):695-701. PubMed ID: 17892994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy.
    Kuchulakanti P; Wolfram R; Torguson R; Rha SW; Cheneau E; Clavijo L; Chu WW; Pinnow EE; Canos D; Satler LF; Suddath WO; Pichard AD; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2005; 6(4):154-9. PubMed ID: 16326376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the "EVOLUTION OFF" trial.
    Koster A; Spiess B; Jurmann M; Dyke CM; Smedira NG; Aronson S; Lincoff MA
    Anesth Analg; 2006 Sep; 103(3):540-4. PubMed ID: 16931658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use and dosing of bivalirudin after temporary total artificial heart implantation: a case series.
    Crouch MA; Kasirajan V; Cahoon W; Katlaps GJ; Gunnerson KJ
    Pharmacotherapy; 2008 Nov; 28(11):1413-20. PubMed ID: 18957002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial.
    White H;
    Lancet; 2001 Dec; 358(9296):1855-63. PubMed ID: 11741625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions.
    Kao J; Lincoff AM; Topol EJ; Madrid A; J Price M; Sawhney N; Teirstein PS
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):352-6. PubMed ID: 16892428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
    Lincoff AM; Bittl JA; Kleiman NS; Sarembock IJ; Jackman JD; Mehta S; Tannenbaum MA; Niederman AL; Bachinsky WB; Tift-Mann J; Parker HG; Kereiakes DJ; Harrington RA; Feit F; Maierson ES; Chew DP; Topol EJ;
    Am J Cardiol; 2004 May; 93(9):1092-6. PubMed ID: 15110198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft patency after off-pump coronary artery bypass surgery is inferior even with identical heparinization protocols: results from the Danish On-pump Versus Off-pump Randomization Study (DOORS).
    Houlind K; Fenger-Grøn M; Holme SJ; Kjeldsen BJ; Madsen SN; Rasmussen BS; Jepsen MH; Ravkilde J; Aaroe J; Hansen PR; Hansen HS; Mortensen PE;
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):1812-1819.e2. PubMed ID: 24613160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation with bivalirudin during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Stella JF; Stella RE; Iaffaldano RA; Stella DJ; Erickson KW; Bliley RC
    J Invasive Cardiol; 2004 Sep; 16(9):451-4. PubMed ID: 15353822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
    Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalirudin compared with heparin during coronary angioplasty for thrombus-containing lesions.
    Shah PB; Ahmed WH; Ganz P; Bittl JA
    J Am Coll Cardiol; 1997 Nov; 30(5):1264-9. PubMed ID: 9350925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
    Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
    Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.